Cancer survivorship care during COVID-19—perspectives and recommendations from the MASCC survivorship study group
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
This editorial draws on the authors’ experiences and the results of a survey of cancer professionals to contextualize the major disruptions taking place globally in survivorship care as a result of the COVID-19 pandemic. Cancer survivors’ follow-up care has been severely affected due to increased risk of infection associated with hospital attendance, limited workforce availability and other resource constraints, implementation of new protocols to screen patients impacting workflow, and concerns of patients and health care providers about risk of infection [1]. Evidence-based recommendations on how to manage cancer survivors in a pandemic are lacking and much of the general guidance (such as CDC guidelines) [2] suggests that clinic visits for cancer survivors, including routine surveillance visits to detect cancer recurrence, should be postponed [3]. Such a situation is problematic especially if the pandemic is long lasting, leaving important survivorship issues and concerns unaddressed. In the absence of appropriate guidelines, cancer survivors are at increased risk of inappropriate or inconsistent follow-up care that could have far-reaching and even life-threatening results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluating the public health impact of health promotion interventions: the RE-AIM framework.
Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.9.1322 · Cited by 7,217
Evaluating barriers to adopting telemedicine worldwide: A systematic review
Scott Kruse, C., Karem, P., Shifflett, K., Vegi, L., Ravi, K., & Brooks, M. (2018) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x16674087 · Cited by 1,735
A Review of Telehealth Service Implementation Frameworks
Van Dyk, L. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110201279 · Cited by 300
Addressing the needs of cancer survivors during the COVID-19 pandemic.
Nekhlyudov, L., Duijts, S., Hudson, S. V., Jones, J. M., Keogh, J., Love, B., Lustberg, M., Smith, K. C., Tevaarwerk, A., Yu, X., et al. (2020) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00884-w · Cited by 130 · cited 1×
“Cancer survivors’ follow-up care has been severely affected due to increased risk of infection associated with hospital attendance, limited workforce availability and other resource constraints, implementation of new protocols to screen patients impacting workflow, and concerns of patients and health care providers ab…”
BackgroundPersonalised cancer follow-up: risk stratification, needs assessment or both?
Watson, E. K., Rose, P. W., Neal, R. D., Hulbert-Williams, N., Donnelly, P., Hubbard, G., Elliott, J., Campbell, C., Weller, D., & Wilkinson, C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.535 · Cited by 106
Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research Priorities
Leach, C. R., Alfano, C. M., Potts, J., Gallicchio, L., Yabroff, K. R., Oeffinger, K. C., Hahn, E. E., Shulman, L. N., & Hudson, S. V. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa053 · Cited by 12
Research works printed but not linked: 9
- van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK et al (2011) The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 47(14):2188–2194 · DOI · Paper page
- Girgis A, Durcinoska I, Koh ES, Ng W, Arnold A, Delaney GP, PROMPT-Care Pathways Working Group (2018) Development of health pathways to standardize cancer care pathways informed by patient-reported outcomes and clinical practice guidelines. JCO Clin Cancer Inform 2:1–13 · DOI
- Kampshoff CS, Verdonck-de Leeuw IM, van Oijen MG, Sprangers MA, Buffart LM (2019). Ecological momentary assessments among patients with cancer: A scoping review. European Journal of Cancer Care. 28: e13095 · DOI · Paper page
- Marandino L, Necchi A, Aglietta M, Di Maio M (2020) COVID-19 emergency and the need to speed up the adoption of electronic patient-reported outcomes in cancer clinical practice. JCO Oncol Pract:OP2000237 · DOI · Paper page
- King DK, Glasgow RE, Leeman-Castillo B (2010) Reaiming RE-AIM: using the model to plan, implement, and evaluate the effects of environmental change approaches to enhancing population health. Am J Public Health 100(11):2076–2084 · DOI · Paper page
- Ke Y, Ng T, Chan A (2018) Survivorship care models for breast cancer, colorectal cancer, and adolescent and young adult (AYA) cancer survivors: a systematic review. Support Care Cancer 26(7):2125–2141 · DOI
- Taylor K, Chan RJ, Monterosso L (2015) Models of survivorship care provision in adult patients with haematological cancer: an integrative literature review. Support Care Cancer 23(5):1447–1458 · DOI
- Alfano CM, Jefford M, Maher J, Birken SA, Mayer DK (2019) Building personalized Cancer follow-up care pathways in the United States: lessons learned from implementation in England, Northern Ireland, and Australia. Am Soc Clin Oncol Educ Book 39:625–639 · DOI · Paper page
- Alfano CM, Mayer DK, Bhatia S, Maher J, Scott JM, Nekhlyudov L et al (2019) Implementing personalized pathways for cancer follow-up care in the United States: proceedings from an American Cancer Society-American Society of Clinical Oncology summit. CA Cancer J Clin 69(3):234–247 · DOI · Paper page
Cited by
Chan, R. J., Crichton, M., Crawford-Williams, F., Agbejule, O. A., Yu, K., Hart, N. H., de Abreu Alves, F., Ashbury, F. D., Eng, L., Fitch, M., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.09.001 · Cited by 144
Self-citationHelsper, C. W., Campbell, C., Emery, J., Neal, R. D., Li, L., Rubin, G., Weert, H., Vedsted, P., Walter, F. M., Weller, D., et al. (2020) · European Journal of Cancer Care · doi:10.1111/ecc.13290 · Cited by 65
Yildiz Kabak, V., Atasavun Uysal, S., & Duger, T. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-020-05965-1 · Cited by 19
Metadata
- Authors
- On behalf of the MASCC Survivorship Study Group, Chan, A., Ashbury, F., Fitch, M. I., Koczwara, B., & Chan, R. J.
- Venue
- Supportive Care in Cancer
- Published
- 2020-05-25
- Volume
- 28
- Issue
- 8
- Pages
- 3485-3488
- ISSN
- 0941-4355 (ISSN-L)
- 1433-7339
- OpenAlex
- W3032774725
- Cited by
- 73
- References
- 6
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.